{"id":10114,"date":"2026-04-09T22:07:46","date_gmt":"2026-04-09T22:07:46","guid":{"rendered":"https:\/\/musictechohio.online\/site\/ai-drug-marketer-medvi-responds\/"},"modified":"2026-04-09T22:07:46","modified_gmt":"2026-04-09T22:07:46","slug":"ai-drug-marketer-medvi-responds","status":"publish","type":"post","link":"https:\/\/musictechohio.online\/site\/ai-drug-marketer-medvi-responds\/","title":{"rendered":"AI-Powered Drug Marketer Medvi Responds After Allegations About Fake Doctors and Patients"},"content":{"rendered":"
\n

Last week, the New York Times <\/em>published a rapturous profile<\/a> of a drug marketing company called Medvi, which the paper declared to be the first one-ish man venture on track to surpass one billion dollars in revenue while leaning almost exclusively on AI to build and scale the business. The news was immediately met with a wave of online backlash over both the framing of the NYT <\/em>piece and the ethics of the company at the center of it \u2014\u00a0and the company\u2019s official response<\/a> raises more questions than it answers.<\/p>\n

Medvi is a company that Futurism <\/em>has been aware of for some time now. It effectively operates as a marketing wrapper for telehealth companies that prescribe and fulfill orders for GLP-1 agonists and other compounded drugs \u2014\u00a0and as we first reported<\/a> all the way back in May 2025, Medvi has engaged in a range of dishonest marketing practices. It\u2019s plastered its website with AI-deepfaked images of phony patients passed off as the real deal, flaunted media logos insinuating that it garnered editorial coverage from mainstream media outlets when it hadn\u2019t, and featured the name and likeness of at least one medical practitioner who told us that in reality he had nothing to do with the company.<\/p>\n

The NYT<\/em>\u2018s profile either downplayed or omitted all of these glaring ethical red flags. The article also definitively stated that Medvi had ceased its practice of using AI-fabricated before-and-after client photos \u2014\u00a0a declaration that, as we pointed out in a follow-up<\/a>, wasn\u2019t true.<\/p>\n

We weren\u2019t the only ones with qualms. As folks from across the health, tech, and business worlds were quick to point out online, at the time the NYT<\/em> article was published, Medvi was being marketed on social media by a trove of Meta accounts featuring clearly fake doctors. In fact, in February 2026, Medvi LLC was issued a warning from the Food and Drug Administration (FDA) pointing to multiple violations on a Medvi-branded site, Medvi.io. In that February warning, the FDA said that the site, Medvi.io, was misleading consumers by featuring images of Medvi-branded pill bottles and vials of injectables \u2014\u00a0Medvi isn\u2019t actually the compounder of any drugs it sells, leaning instead on various pharmacies \u2014\u00a0and suggesting that certain drug compounds Medvi peddles are FDA-approved when they aren\u2019t. Both the fake doctors on social media and the FDA warning went unmentioned in the NYT<\/em> piece.<\/p>\n

Yesterday, in response to public backlash and new reporting from outlets including Futurism, Techdirt<\/a>, Business Insider<\/a>, <\/em>and the pharma-focused outlet Drug Discovery & Development<\/a><\/em>, Medvi and its founder, 41-year-old Matthew Gallagher, issued a statement that it characterized as a \u201cresponse to external speculation\u201d about the company and its marketing practices.<\/p>\n

The statement Medvi provided focuses heavily on the context surrounding the FDA warning, noting that \u201cin September 2025 and February 2026, the FDA sent an unprecedented number of warning letters to dozens of telehealth companies, drug companies and pharmacies regarding their direct-to-consumer advertising practices.\u201d This is true: as we noted in our previous story, Medvi was one of numerous companies<\/a> issued stark warnings amid a broader crackdown on the unruly GLP-1 marketplace.<\/p>\n

But while the FDA letter is addressed to Medvi LLC, Medvi is insisting that it was an affiliate \u2014\u00a0basically, another marketer that funnels patients to Medvi in exchange for a financial kickback \u2014\u00a0that was technically in violation of the FDA\u2019s warning.<\/p>\n

\u201cIn one of the FDA\u2019s letters, the URL mentioned is medvi.io \u2014\u00a0not MEDVi\u2019s actual address of medvi.org,\u201d reads the statement, which is attributed to Gallagher. \u201cThe letter addressed to MEDVi was directed at an affiliate marketing agency whose website contained outdated copy. We immediately reached out to the affiliate and required them to remove the materials allegedly at issue. We understand the affiliate also directly responded to the FDA.\u201d<\/p>\n

\u201cMy company MEDVi has never received a letter from the FDA,\u201d the statement continues. \u201cIf we were to receive such a communication from any regulatory authority, we would act swiftly and collaboratively to address the matter.\u201d<\/p>\n

In response, we asked whether Medvi LLC \u2014 the company the FDA letter was addressed to \u2014 is Gallagher\u2019s company that was featured in the NYT<\/em>. We haven\u2019t received any response.<\/p>\n

When we first reported on the stolen before-and-after images on Medvi.io, the site had no affiliate disclaimers, and directed us to contact help@medvi.org<\/a> with inquiries \u2014 the email that Medvi.org, which Medvi insists is its primary domain, still directs site-goers to today.<\/p>\n

We asked Medvi when Medvi.io changed hands to an affiliate, and who this affiliate was, which also went unanswered.<\/p>\n

Further, at the time the letter said Medvi.io was in violation of FDA guidelines \u2014 December 2025 \u2014 Medvi.org\u2019s homepage featured<\/a> the same AI-generated Medvi-branded bottles that the FDA warning said were \u201cfalse or misleading\u201d to consumers, as they suggested that Medvi is the compounder of the drugs it sells when it isn\u2019t. According to archived versions of the site, Medvi.org appeared to have taken these images down after the FDA warning in February.<\/p>\n

And yet, as of publishing this article, a functioning \u201cwelcome<\/a>\u201d page hosted by Medvi.org continues to prominently feature images of Medvi-labeled drugs \u2014 including a Medvi-branded bottle of oral tirzepatide tablets. Words on the bottle describe the tablets as \u201ccompounded medication\u201d for \u201cmedical weight management.\u201d<\/p>\n

But oral tirzepatide isn\u2019t<\/a> FDA-approved for weight loss. In fact, while injectable tirzepatide is FDA-approved<\/a> \u2014\u00a0tirzepatide is the active ingredient found in Eli Lilly\u2019s Zepbound shot \u2014 the tablet version of the drug has no proven benefits<\/a>. There\u2019s no evidence that it\u2019ll actually help buyers lose weight.<\/p>\n

\u201cWhy don\u2019t I just compound a little piece of cardboard and give it to you?\u201d Dr. Jon Slotkin, a neurosurgeon and hospital executive at a large hospital system in Pennsylvania, told Futurism <\/em>of the dubious compound. \u201cThere is exactly as much human data published that oral tirzepatide will help you lose weight as there is published data that compounded cardboard in a little tablet will help you lose weight. They\u2019re identical in their amount of evidence.\u201d<\/p>\n

\"A<\/figure>\n

The same page also features images of AI-generated doctors in Medvi-branded lab coats. A label of one bottle reads \u201cMedvi Pharmacy\u201d and features instructions urging patients to \u201ctake one table [sic] by mouth twice daily.\u201d<\/p>\n

The page directs to a Medvi patient portal, and there are no affiliate caveats or disclaimers about FDA approval.<\/p>\n

A webpage for medvi.org\/welcome featuring an AI-generated doctor with a lab coat that says \"Medvi\"<\/figure>\n
A webpage for medvi.org\/welcome featuring an AI-generated bottle Medvi-branded medication. The bottle reads \"Medvi pharmacy\" and instructs people to \"take on table [sic] by mouth twice daily.\"<\/figure>\n

We asked Medvi whether Medvi.org was in violation of FDA guidelines at the time the warning was sent, and to clarify whether the operational \u201cwelcome\u201d page we found was operated by Medvi LLC and in compliance with FDA rules. Again, we haven\u2019t received any answer.<\/p>\n

Elsewhere, Medvi\u2019s statement addresses the controversy surrounding what the company describes as \u201c\u2018so-called\u2019 fake doctors,\u201d claiming that it only \u201crecently become aware of what appear to be advertisements featuring potentially AI-generated medical practitioners.\u201d (Many of these accounts were deleted or altered almost immediately following inquiries from journalists.)<\/p>\n

\u201cSince we became aware of this issue, we have updated our marketing practices to make clear that this type of advertising and \/ or promotion is prohibited,\u201d the statement continued. \u201cWe continue to proactively address this issue.\u201d (\u201cProactively\u201d means<\/a> addressing something before it becomes an issue, not after you\u2019re called out for it.)<\/p>\n

Medvi\u2019s response also failed to address the venture\u2019s continued use of AI-generated before-and-after patient pictures. Asked whether it believes the use of fake, AI-generated patients is ethical, Medvi didn\u2019t respond.<\/p>\n

Still, the statement went on to say that Medvi is committed to \u201coperating transparently.\u201d<\/p>\n

\u201cBuilding a company the size of MEDVi and scaling so quickly involves many learning moments. At each of these stages, I have course-corrected immediately and appropriately. I will continue to do so,\u201d Gallagher said in the statement. <\/em>\u201cThe New York Times <\/em>was recently given unprecedented access to MEDVi\u2019s business information and also interviewed our business partners and other collaborators.\u201d<\/p>\n

\u201cAs I continue helping our customers achieve their health goals,\u201d he added, \u201cI remain committed to building and operating transparently.\u201d<\/p>\n

More on Medvi: <\/strong>Why Is the New York Times Laundering the Reputation of a Sleazy AI Startup That\u2019s Selling GLP-1s via a Dishonest Dumpster Fire of Fake Doctors, Phony Before-and-After Pictures, and Other Glaring Red Flags?<\/a><\/em><\/p>\n

\n

The post AI-Powered Drug Marketer Medvi Responds After Allegations About Fake Doctors and Patients<\/a> appeared first on Futurism<\/a>.<\/p>\n<\/div>\n

<\/div>","protected":false},"excerpt":{"rendered":"

Last week, the New York Times published a rapturous profile of a drug marketing company called Medvi, which the paper declared to be the first one-ish man venture on track…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[177,3841,3844,3955,4164,4165],"tags":[],"class_list":["post-10114","post","type-post","status-publish","format-standard","hentry","category-artificial-intelligence","category-ethics","category-health-medicine","category-medical","category-rx-and-medicine","category-treatments"],"_links":{"self":[{"href":"https:\/\/musictechohio.online\/site\/wp-json\/wp\/v2\/posts\/10114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/musictechohio.online\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/musictechohio.online\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/musictechohio.online\/site\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/musictechohio.online\/site\/wp-json\/wp\/v2\/comments?post=10114"}],"version-history":[{"count":0,"href":"https:\/\/musictechohio.online\/site\/wp-json\/wp\/v2\/posts\/10114\/revisions"}],"wp:attachment":[{"href":"https:\/\/musictechohio.online\/site\/wp-json\/wp\/v2\/media?parent=10114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/musictechohio.online\/site\/wp-json\/wp\/v2\/categories?post=10114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/musictechohio.online\/site\/wp-json\/wp\/v2\/tags?post=10114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}